1-[(E)-3-[4-[2-(dimethylamino)ethoxy]-3,5-dimethoxyphenyl]prop-2-enoyl]-2,3-dihydropyridin-6-one | 1268593-79-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 1-[(E)-3-[4-[2-(dimethylamino)ethoxy]-3,5-dimethoxyphenyl]prop-2-enoyl]-2,3-dihydropyridin-6-one
• CAS: 1268593-79-8
• 化学式: C₂₀H₂₆N₂O₅
• 分子量: 374.437
• InChiKey: FMGMZBMADZKXRH-CMDGGOBGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  68.3
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  荜茇酰胺 在 aluminum (III) chloride 、 diisopropyl (E)-azodicarboxylate 、 三苯基膦 作用下， 以 四氢呋喃 、 二氯甲烷 、 甲苯 为溶剂， 反应 4.17h， 生成 1-[(E)-3-[4-[2-(dimethylamino)ethoxy]-3,5-dimethoxyphenyl]prop-2-enoyl]-2,3-dihydropyridin-6-one
  参考文献：
  名称：

  Compounds, Compositions, and Methods for Cancer Therapy

  摘要：

  本文披露了包括各种辣椒酸丁酯的寡聚体和/或辣椒酸丁酯类似物以及表现出对癌细胞有改进毒性的某些辣椒酸丁酯类似物的化合物。还提供了包括这些化合物的组合物、制备包括这些化合物的组合物的方法、制备这些化合物的方法，以及在治疗癌症方法中使用这些化合物的用途。

  公开号：

  US20140024639A1

文献信息

• Compounds and Compositions For Treating Cancer
  申请人：Foley Michael Andrew

  公开号：US20110053938A1

  公开（公告）日：2011-03-03

  The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.

  本发明涉及用于治疗和预防癌症的化合物和组合物。该发明还涵盖了通过有选择性地调节疾病细胞与正常细胞中反应性氧化物水平来治疗的所有疾病。还公开了制备和管理这种组合物的方法。
• Small molecule anti-scarring agents
  申请人：UNIVERSITY OF ROCHESTER

  公开号：US10548911B2

  公开（公告）日：2020-02-04

  Disclosed are methods of treating fibrosis in a patient in need thereof that includes administering to the patient an amount of an active agent, as identified herein, that is therapeutically effective to inhibit myofibroblast formation and thereby treat the fibrosis. Also disclosed is a recombinant cell line that includes a recombinant gene that expresses a detectable expression product in a dose-dependent response to TGFβ, as well as methods of identifying a compound that inhibits TGFβ-mediated expression of the detectable expression product.

  公开了治疗有需要的患者纤维化的方法，包括向患者施用一定量的本文所确定的活性剂，该活性剂对抑制肌成纤维细胞的形成从而治疗纤维化具有治疗效果。还公开了一种重组细胞系，该细胞系包括以对TGFβ的剂量依赖性反应表达可检测表达产物的重组基因，以及鉴定抑制TGFβ介导的可检测表达产物表达的化合物的方法。
• Compositions and methods for selectively depleting senescent cells
  申请人：BioVentures, LLC

  公开号：US10758524B2

  公开（公告）日：2020-09-01

  The present disclosure provides compositions and methods for selectively killing senescent cells, wherein the composition comprises piperlongumine (PL) or derivative thereof. The selective killing of senescent cells may delay aging and/or treat age-related disorders.

  本公开提供了选择性杀死衰老细胞的组合物和方法，其中组合物包括哌隆罗明（PL）或其衍生物。 选择性杀死衰老细胞可延缓衰老和/或治疗与年龄有关的疾病。
• Compounds And Compositions For Treating Cancer
  申请人：ELLIOTT PETER

  公开号：US20120059004A1

  公开（公告）日：2012-03-08

  The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
• Compounds and Compositions for Treating Cancer
  申请人：THE GENERAL HOSPITAL CORPORATION

  公开号：US20130237539A1

  公开（公告）日：2013-09-12

  The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.